BRIV_adv
Annals of Indian Academy of Neurology
  Users Online: 260 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
This article has been cited by
1Application of ? free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm
Estefania Valencia-Vera,Ana Martinez-Escribano Garcia-Ripoll,Alfredo Enguix,Carmen Abalos-Garcia,Maria Jesus Segovia-Cuevas
Clinical Chemistry and Laboratory Medicine (CCLM).2018;56(4)609
[DOI]
2The impact of regional astrocyte interferon-? signaling during chronic autoimmunity: a novel role for the immunoproteasome
Brandon C. Smith,Maksim Sinyuk,Julius E. Jenkins,Morgan W. Psenicka,Jessica L. Williams
Journal of Neuroinflammation.2020;17(1)609
[DOI]
3Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population
Hasan Simsek,Hikmet Geckin,Nilay Padir Sensoz,Edward O. List,Ahmet Arman
Journal of Molecular Neuroscience.2019;67(1)38
[DOI]
4Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population
Nages Nagaratnam,Kujan Nagaratnam,Gary Cheuk
Journal of Molecular Neuroscience.2017;67(1)1
[DOI]
5Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis
Chiara Parravicini,Davide Lecca,Davide Marangon,Giusy Tindara Coppolino,Simona Daniele,Elisabetta Bonfanti,Marta Fumagalli,Luca Raveglia,Claudia Martini,Elisabetta Gianazza,Maria Letizia Trincavelli,Maria P. Abbracchio,Ivano Eberini,Fernando de Castro
PLOS ONE.2020;15(4)e0231483
[DOI]
6The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada
Wenqing Su,Anuraag Kansal,Colin Vicente,Baris Deniz,Sujata Sarda
Journal of Medical Economics.2016;19(7)718
[DOI]
7Impact of Delayed Diagnosis and Treatment in Clinically Isolated Syndrome and Multiple Sclerosis
Patricia Kennedy
Journal of Neuroscience Nursing.2013;45(6)S3
[DOI]
8Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
Lee A. Tan,Manish K. Kasliwal,Christopher C. Muth,Dusan Stefoski,Vincent C. Traynelis
Journal of Clinical Neuroscience.2014;21(12)2189
[DOI]
9An overview of lipidomic analysis in different human matrices of multiple sclerosis
Helena Beatriz Ferreira,Bruna Neves,Inês M. Guerra,Ana Moreira,Tânia Melo,Artur Paiva,M. Rosário Domingues
Multiple Sclerosis and Related Disorders.2020;44(12)102189
[DOI]
10Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands
Arthur Derksen,Lidwine B. Mokkink,Marc B. Rietberg,Dirk L. Knol,Raymond W. J. G. Ostelo,Bernard M. J. Uitdehaag
Quality of Life Research.2013;22(9)2435
[DOI]
11Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands
Nages Nagaratnam,Kujan Nagaratnam,Gary Cheuk
Quality of Life Research.2018;22(9)337
[DOI]
12Glatiramer acetate: A complex drug beyond biologics
Paolo Rocco,Ivano Eberini,Umberto M. Musazzi,Silvia Franzè,Paola Minghetti
European Journal of Pharmaceutical Sciences.2019;133(9)8
[DOI]
13Türk Popülasyonu’nda Tümor Nekroz Faktör Alfa Gen Polimorfizmi (-376) ile Multipl Skleroz Arasindaki Iliski
Ahmet Arman,Hasan Simsek
Marmara Fen Bilimleri Dergisi.2018;133(9)8
[DOI]
14White matter lesion loads associated with dynamic functional connectivity within attention network in patients with relapsing-remitting multiple sclerosis
Muhua Huang,Fuqing Zhou,Lin Wu,Bo Wang,Linghong Guo,Yanlin Zhao,Hui Wan,Fangjun Li,Xianjun Zeng,Honghan Gong
Journal of Clinical Neuroscience.2019;65(9)59
[DOI]
15Is Decompressive Surgery for Cervical Spondylotic Myelopathy Effective in Patients Suffering from Concomitant Multiple Sclerosis or Parkinson’s Disease?
Taylor Purvis,Daniel Lubelski,Thomas Mroz
Brain Sciences.2017;7(12)39
[DOI]
16Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis
Helena Beatriz Ferreira,Tânia Melo,Andreia Monteiro,Artur Paiva,Pedro Domingues,M. Rosário Domingues
Archives of Biochemistry and Biophysics.2021;697(12)108672
[DOI]
17Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis
Rui D. Prediger,Marissa G. Schamne,Tuane B. Sampaio,Eduardo L.G. Moreira,Daniel Rial
Archives of Biochemistry and Biophysics.2019;164(12)431
[DOI]
18Altered Inter-Subregion Connectivity of the Default Mode Network in Relapsing Remitting Multiple Sclerosis: A Functional and Structural Connectivity Study
Fuqing Zhou,Ying Zhuang,Honghan Gong,Bo Wang,Xing Wang,Qi Chen,Lin Wu,Hui Wan,Chunshui Yu
PLoS ONE.2014;9(7)e101198
[DOI]
19Plasma proteome in multiple sclerosis disease progression
Arjan Malekzadeh,Cyra Leurs,Wessel Wieringen,Martijn D. Steenwijk,Menno M. Schoonheim,Michael Amann,Yvonne Naegelin,Jens Kuhle,Joep Killestein,Charlotte E. Teunissen
Annals of Clinical and Translational Neurology.2019;6(9)1582
[DOI]
20Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis
Ying Zhuang,Fuqing Zhou,Honghan. Gong,Francisco J. Esteban
PLOS ONE.2015;10(6)e0130524
[DOI]
21miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis
Aya A. Elkhodiry,Dina A. Zamzam,Hend M. El Tayebi
Multiple Sclerosis and Related Disorders.2021;53(6)103078
[DOI]
22Perspectives from the patient: A content analysis of communication changes, impact, and strategies to facilitate communication in multiple sclerosis
S. El-Wahsh,C. Layfield,H. Bogaardt,F. Kumfor,K. J. Ballard
International Journal of Speech-Language Pathology.2021;53(6)1
[DOI]
23The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada
Emily Dorman,Anuraag R. Kansal,Sujata Sarda
Journal of Medical Economics.2015;18(12)1085
[DOI]
24Relationship between miR-155 and miR-146a polymorphisms and susceptibility to multiple sclerosis in an Egyptian cohort
Marwa Ali,Olfat Shaker,Hanaa Eid,Eman Mahmoud,Eman Ezzat,Sylvana Gaber
Biomedical Reports.2020;18(12)1085
[DOI]
25Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
Frida Duell,Björn Evertsson,Faiez Al Nimer,Åsa Sandin,Daniel Olsson,Tomas Olsson,Mohsen Khademi,Max Albert Hietala,Fredrik Piehl,Magnus Hansson
Neurology - Neuroimmunology Neuroinflammation.2020;7(4)e775
[DOI]
26Increased thalamic intrinsic oscillation amplitude in relapsing–remitting multiple sclerosis associated with the slowed cognitive processing
FuQing Zhou,Ying Zhuang,Lin Wu,Ning Zhang,XianJun Zeng,HongHan Gong,Chi-Shing Zee
Clinical Imaging.2014;38(5)605
[DOI]
27Genetic disorders with central nervous system white matter abnormalities: An update
Anju Shukla,Parneet Kaur,Dhanya Lakshmi Narayanan,Michelle C. do Rosario,Rajagopal Kadavigere,Katta Mohan Girisha
Clinical Genetics.2021;99(1)119
[DOI]
28Correlating the Physical Activity Patterns of People with Moderate to Severe Multiple Sclerosis Disability and Their Family Caregivers
Afolasade Fakolade,Marcia Finlayson,Trisha Parsons,Amy Latimer-Cheung
Physiotherapy Canada.2018;70(4)373
[DOI]
29Interpretable deep learning as a means for decrypting disease signature in multiple sclerosis
F Cruciani,L Brusini,M Zucchelli,G Retuci Pinheiro,F Setti,I Boscolo Galazzo,R Deriche,L Rittner,M Calabrese,G Menegaz
Journal of Neural Engineering.2021;18(4)0460a6
[DOI]
30Interpretable deep learning as a means for decrypting disease signature in multiple sclerosis
Federica Cruciani,Lorenza Brusini,Mauro Zucchelli,Gustavo Retuci Pinheiro,Francesco Setti,Ilaria Boscolo Galazzo,Rachid Deriche,Leticia Rittner,Massimiliano Calabrese,Gloria Menegaz
Journal of Neural Engineering.2021;12663(4)103
[DOI]
31Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis
Joseph T. Ciccolo,Albert C. Lo,Ernestine G. Jennings,Robert W. Motl
Contemporary Clinical Trials.2012;33(4)848
[DOI]
32Therapeutic Approaches toward Multiple Sclerosis: Where Do We Stand and Where Are We Headed?
Rui Pedro Moura,Bruno Sarmento
Advanced Therapeutics.2019;2(10)1900070
[DOI]
33Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis
Tanima Bose
Brain Sciences.2017;7(12)148
[DOI]
34Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?
Morgan W. Psenicka,Brandon C. Smith,Rachel A. Tinkey,Jessica L. Williams
Frontiers in Cellular Neuroscience.2021;15(12)148
[DOI]
35Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis
Fuqing Zhou,Honghan Gong,Qi Chen,Bo Wang,Yan Peng,Ying Zhuang,Chi-shing Zee
Frontiers in Human Neuroscience.2016;10(12)148
[DOI]
  About this journal 
  Editorial Board 
  Online Submission 
  Current Issue 
  Archives 
  Ahead of print 
  Instructions to Authors 
  Subscription
  Alerting 
  Feedback 

Submit Articles

Alerts

Join us